Results of interventions on the celiac plexus in treating patients with chronic pharmacoresistant abdominal pain

Authors

DOI:

https://doi.org/10.25305/unj.301385

Keywords:

neurolysis, sympatholysis, celiac plexus, solar plexus, pancreatic cancer, abdominal pain, solaritis, functional abdominal pain syndrome

Abstract

Patients with chronic abdominal pain are a complex cohort of patients who undergo treatment by many specialists for a long time: surgeons, urologists, gynecologists, neurologists, psychiatrists, etc. However, despite all diagnostic and treatment measures, the pain syndrome persists or worsens.

Objective ‒ evaluation of the effectiveness, safety and long-term results of treating patients with abdominal pain syndromes, which includes the use of various methods of minimally invasive interventions on the celiac plexus (CP) taking into account the peculiarities of the origin, nature and localization of pain.

Materials and methods. An analysis of the results of 26 interventions on CP in 21 patients was performed. Inclusion criteria for participants in the study were individuals with persistent pharmacoresistant abdominal pain for ≥3 months, aged 19 to 73 years. There were 13 (62.0%) male and 8 (38.0%) were female. Mean age was 55.2±15.2 years. Patients were divided into two groups. The first (n=16) included patients with pancreatic cancer, the second (n=5) included patients with non-oncological chronic abdominal pain syndromes: functional abdominal pain syndrome was diagnosed in three cases, and one observation each of solaritis and chronic pancreatitis.

All procedures were performed under CT. To assess the intensity of the pain syndrome, a visual analogue scale (VAS) of pain from 1 to 10 cm was used, where 0 cm is the absence of pain, 10 cm is unbearable pain; functional status (FS) - according to the Karnofsky scale (KS) from 0 to 100%. Estimation of the daily dose of opioid analgesics was estimated using the oral morphine equivalent daily dose (oMEDD). Patients were observed for 6 months, evaluations were carried out after 1 week, 1, 3 and 6 months, respectively.

Results. In the first group, 17 interventions on CP were performed in 16 participants, sympatholysis was performed twice in one patient. In the second group - 9 interventions in 5 patients: 4 Celiac Plexus Blocks (CPBs) of the central nervous system using "Depo-Medrol®" (methylprednisolone) and 5 neurolysis with 96% ethyl alcohol. Two patients were initially treated with CPB and then sympatholysis due to the recurrence of pain syndrome with the aim of a more stable sympatholytic and analgesic effect. In one patient, neurolysis of CP was performed three times. In all cases, no complications were recorded during the procedures.

VAS before the procedure in the general group (n=26) was 9.6±0.6 cm, one week after the intervention it was 4.5±1.6 cm (P<0.0001), after one month it was 3.2±1 .5 cm (P<0.0001), after 3 months – 3.0±1.6 cm (P<0.0001), after six months – 4.4±1.6 cm (P<0.0001). The FS indicator according to the KS before the procedure in the general group was 65.8±7.0%, one week after the intervention – 80.8±8.0% (P<0.0001), one month later – 81.5±8.3 % (P<0.0001), after 3 months – 75.0±9.5% (P<0.0010), after six months – 68.0±9.4% (P=0.4042). The oral morphine equivalent daily dose before the procedure in the general group was 123.8±86.0 mg per day, one week after the intervention on CP oMEDD was 57.3±61.2 mg (P<0.0001), after 1 month – 41.0±47.3 mg (P<0.0001), after 3 months – 44.0±51.3 mg (P<0.0001), after 6 months – 80.6±77.2 mg (P<0,0001).

Conclusions. Computed tomography-guided celiac plexus neurolysis is a useful and effective tool in treating patients with both abdominal pain caused by inoperable pancreatic cancer and chronic non-oncological pharmacoresistant abdominal pain. Minimally invasive interventions on CP provide a significant reduction of pain syndrome according to the VAS scale (p<0.001), reduce the need to take opioids analgesics (p<0.001) after 1, 3, 6 months and increase the FS of patients according to the KS (p<0.001) after 1, 3 months. Taking into account the high percentage of recurrence of pain syndrome in the studied patients of the group of non-oncology pain, the need for repeated interventions for the purpose of long-term pain control, interventions on CP in this cohort of patients require further research with an increase in the number of observations.

References

1. Hoppenfeld J.D. Fundamentals of Pain Medicine: How to Diagnose and Treat your Patients. Lippincott Williams & Wilkins; 2014. 288 p.

2. Cuomo A, Cascella M, Forte CA, Bimonte S, Esposito G, De Santis S, Cavanna L, Fusco F, Dauri M, Natoli S, Maltoni M, Morabito A, Mediati RD, Lorusso V, Barni S, Porzio G, Mercadante S, Crispo A. Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study. J Clin Med. 2020 Apr 2;9(4):1003. [CrossRef] [PubMed] [PubMed Central]

3. Urits I, Jones MR, Orhurhu V, Peck J, Corrigan D, Hubble A, Andrews M, Feng R, Manchikanti L, Kaye AD, Kaye RJ, Viswanath O. A Comprehensive Review of the Celiac Plexus Block for the Management of Chronic Abdominal Pain. Curr Pain Headache Rep. 2020 Jun 11;24(8):42. [CrossRef] [PubMed]

4. Koulouris AI, Banim P, Hart AR. Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments. Dig Dis Sci. 2017 Apr;62(4):861-870. [CrossRef] [PubMed]

5. Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG 3rd, McCann RL, Pappas TN, Tyler DS, Scarborough JE. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol. 2012 Dec;19(13):4068-77. [CrossRef] [PubMed]

6. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995 Dec 20;274(23):1870-3. [CrossRef] [PubMed]

7. Kaufman M, Singh G, Das S, Concha-Parra R, Erber J, Micames C, Gress F. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010 Feb;44(2):127-34. [CrossRef] [PubMed]

8. Neuwersch-Sommeregger S, Köstenberger M, Stettner H, Pipam W, Breschan C, Feigl G, Likar R, Egger M. CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients. Pain Ther. 2021 Dec;10(2):1593-1603. [CrossRef] [PubMed] [PubMed Central]

9. Dumitrescu A, Aggarwal A, Chye R. A retrospective case series of patients who have undergone coeliac plexus blocks for the purpose of alleviating pain due to intra-abdominal malignancy. Cancer Rep (Hoboken). 2020 Oct;3(5):e1265. [CrossRef] [PubMed] [PubMed Central]

10. Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006 Oct;7(10):797-809. [CrossRef] [PubMed]

11. Eroshkin AA, Romanukha DM. CT-guided Celiac Plexus Neurolysis in the Management of Severe Upper Abdominal Pain. Ukr Neurosurg J. 2020 Jun 18;26(2):34-45. [CrossRef]

12. Tack J, Drossman DA. What's new in Rome IV? Neurogastroenterol Motil. 2017 Sep;29(9).[CrossRef] [PubMed]

13. Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr 30;23(2):151-163. [CrossRef] [PubMed][PubMed Central]

14. Patrizi F, Freedman SD, Pascual-Leone A, Fregni F. Novel therapeutic approaches to the treatment of chronic abdominal visceral pain. ScientificWorldJournal. 2006 Apr 18;6:472-90. [CrossRef] [PubMed] [PubMed Central]

15. Goulden MR. The pain of chronic pancreatitis: a persistent clinical challenge. Br J Pain. 2013 Feb;7(1):8-22. [CrossRef] [PubMed] [PubMed Central]

16. Pezzilli R, Morselli-Labate AM, Fantini L, Campana D, Corinaldesi R. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis. 2007 Dec;39(12):1077-86. [CrossRef] [PubMed]

17. Wehler M, Nichterlein R, Fischer B, Farnbacher M, Reulbach U, Hahn EG, Schneider T. Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol. 2004 Jan;99(1):138-46. [CrossRef] [PubMed]

18. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995 Feb;80(2):290-5. [CrossRef] [PubMed]

19. Vig S, Bhan S, Bhatnagar S. Celiac Plexus Block - An Old Technique with New Developments. Pain Physician. 2021 Aug;24(5):379-398. [PubMed]

20. Eroshkin ОA, Romanukha DM. Minimally invasive interventions on celiac plexus in patients with persistent abdominal pain caused by pancreatic cancer. INT NEUROL J. Mar 20;20(1):13-22. [CrossRef]

21. Mohamed RE, Amin MA, Omar HM. Computed tomography-guided celiac plexus neurolysis for intractable pain of unresectable pancreatic cancer. The Egyptian Journal of Radiology and Nuclear Medicine. 2017 Sep 1;48(3):627-37. [CrossRef]

22. Romanukha DM, Strokan AM, Biloshytsky VV. The use of different methods of celiac plexus neurolysis in the treatment of pain syndrome associated with pancreatic cancer. Ukr Neurosurg J. 2022 Sep 29;28(3):52-6. [CrossRef]

23. Rai P, Cr L, Kc H. Endoscopic ultrasound-guided celiac plexus neurolysis improves pain in gallbladder cancer. Indian J Gastroenterol. 2020 Feb 17. [CrossRef] [PubMed]

24. Jin G, Qiu X, Ding M, Dai M, Zhang X. Navigated magnetic resonance imaging-guided celiac plexus neurolysis using an open magnetic resonance system for pancreatic cancer patients with upper abdominal pain. J Cancer Res Ther. 2019;15(4):825-830. [CrossRef] [PubMed]

25. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD007519. [CrossRef] [PubMed] [PubMed Central]

26. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257-61. [CrossRef] [PubMed]

27. Sperber AD, Drossman DA. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther. 2011 Mar;33(5):514-24. [CrossRef] [PubMed]

28. Drossman DA. Presidential address: Gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998 May-Jun;60(3):258-67. [CrossRef] [PubMed]

29. First HB, Frances A, Pincus HA. DSM-IV-TR Guidebook. Washington, DC: American Psychiatric Publishing, 2004.

30. Drossman DA. Medicine has become a business, but what is the cost? Gastroenterology. 2004 Apr;126(4):952-3. [CrossRef] [PubMed]

31. Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1126-39; quiz 1121-2. [CrossRef] [PubMed] [PubMed Central]

32. Drossman DA. Severe and refractory chronic abdominal pain: treatment strategies. Clin Gastroenterol Hepatol. 2008 Sep;6(9):978-82. [CrossRef] [PubMed]

33. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996 Dec;68(2-3):217-27. [CrossRef] [PubMed]

34. Sabo CM, Grad S, Dumitrascu DL. Chronic Abdominal Pain in General Practice. Dig Dis. 2021;39(6):606-614. [CrossRef] [PubMed]

35. Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K, Whorwell PJ. Centrally Mediated Disorders of Gastrointestinal Pain. Gastroenterology. 2016 Feb 19:S0016-5085(16)00225-0. [CrossRef] [PubMed]

36. Rana MV, Candido KD, Raja O, Knezevic NN. Celiac plexus block in the management of chronic abdominal pain. Curr Pain Headache Rep. 2014 Feb;18(2):394. [CrossRef] [PubMed]

37. Choi JW, Joo EY, Lee SH, Lee CJ, Kim TH, Sim WS. Radiofrequency thermocoagulation of the thoracic splanchnic nerve in functional abdominal pain syndrome -A case report-. Korean J Anesthesiol. 2011 Jul;61(1):79-82. [CrossRef] [PubMed] [PubMed Central]

38. Liou H, Kong MJ, Alzubaidi SJ, Knuttinen MG, Patel IJ, Kriegshauser JS. Single-Center Review of Celiac Plexus/Retrocrural Splanchnic Nerve Block for Non-Cancer Related Pain. Acad Radiol. 2021 Nov;28 Suppl 1:S244-S249. [CrossRef] [PubMed]

39. Laignel-Lavastine M. Pathologie du sympathique. Paris: Alcan, 1924.

40. Maratka Z. Celiac (solar) plexus syndrome. A frequently overlooked source of abdominal pain. J Clin Gastroenterol. 1993 Mar;16(2):95-7. [PubMed]

41. Maratka Z. Comments on Rome criteria of functional gastrointestinal disorders. Hepatogastroenterology. 2007 Mar;54(74):454-7. [PubMed]

42. Mařatka Z. Functional gastrointestinal disorders – 50 years’ experience in comparison with the Rome criteria. Folia Gastroenterol Hepatol 2005;3(1):10-16. http://mobile.pro-folia.org/files/1/2005/1/maratka.pdf

43. Reidenberg MM, Portenoy RK. The need for an open mind about the treatment of chronic nonmalignant pain. Clin Pharmacol Ther. 1994 Apr;55(4):367-9. [CrossRef] [PubMed]

44. Gabbrielli A, Pandolfi M, Mutignani M, Spada C, Perri V, Petruzziello L, Costamagna G. Efficacy of main pancreatic-duct endoscopic drainage in patients with chronic pancreatitis, continuous pain, and dilated duct. Gastrointest Endosc. 2005 Apr;61(4):576-81. [CrossRef] [PubMed]

45. Chauhan S, Forsmark CE. Pain management in chronic pancreatitis: A treatment algorithm. Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):323-35. [CrossRef] [PubMed]

46. Fasanella KE, Davis B, Lyons J, Chen Z, Lee KK, Slivka A, Whitcomb DC. Pain in chronic pancreatitis and pancreatic cancer. Gastroenterol Clin North Am. 2007 Jun;36(2):335-64, ix. [CrossRef] [PubMed]

47. Lieb JG 2nd, Forsmark CE. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther. 2009 Apr 1;29(7):706-19. [CrossRef] [PubMed]

48. Dumonceau JM, Costamagna G, Tringali A, Vahedi K, Delhaye M, Hittelet A, Spera G, Giostra E, Mutignani M, De Maertelaer V, Devière J. Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial. Gut. 2007 Apr;56(4):545-52. [CrossRef] [PubMed] [PubMed Central]

49. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage. 1992 Feb;7(2):69-77. [CrossRef] [PubMed]

50. Vera-Portocarrero L, Westlund KN. Role of neurogenic inflammation in pancreatitis and pancreatic pain. Neurosignals. 2005;14(4):158-65. [CrossRef] [PubMed] [PubMed Central]

51. Fusaroli P, Caletti G. Is there a role for celiac plexus block for chronic pancreatitis? Endosc Int Open. 2015 Feb;3(1):E60-2. [CrossRef] [PubMed] [PubMed Central]

52. Kapural L, Jolly S. Interventional Pain Management Approaches for Control of Chronic Pancreatic Pain. Curr Treat Options Gastroenterol. 2016 Sep;14(3):360-70. [CrossRef] [PubMed]

53. Maydeo A, Kamat N, Dalal A, Patil G. Advances in the Management of Pain in Chronic Pancreatitis. Curr Gastroenterol Rep. 2023 Oct;25(10):260-266. [CrossRef] [PubMed]

54. Cohen SM, Kent TS. Etiology, Diagnosis, and Modern Management of Chronic Pancreatitis: A Systematic Review. JAMA Surg. 2023 Jun 1;158(6):652-661. [CrossRef] [PubMed]

55. Gress F, Schmitt C, Sherman S, Ciaccia D, Ikenberry S, Lehman G. Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol. 2001 Feb;96(2):409-16. [CrossRef] [PubMed]

56. Sey MS, Schmaltz L, Al-Haddad MA, DeWitt JM, Calley CS, Juan M, Lasisi F, Sherman S, McHenry L, Imperiale TF, LeBlanc JK. Effectiveness and safety of serial endoscopic ultrasound-guided celiac plexus block for chronic pancreatitis. Endosc Int Open. 2015 Feb;3(1):E56-9. [CrossRef] [PubMed] [PubMed Central]

57. Santosh D, Lakhtakia S, Gupta R, Reddy DN, Rao GV, Tandan M, Ramchandani M, Guda NM. Clinical trial: a randomized trial comparing fluoroscopy guided percutaneous technique vs. endoscopic ultrasound guided technique of coeliac plexus block for treatment of pain in chronic pancreatitis. Aliment Pharmacol Ther. 2009 May 1;29(9):979-84. [CrossRef] [PubMed]

58. Cho NR, Kim YN, Kim JY, Ko YR, Hong TH, Moon HK, Park HJ. Celiac plexus block with botulinum toxin in severe chronic pancreatitis-A case report. J Clin Pharm Ther. 2020 Aug;45(4):848-851. [CrossRef] [PubMed]

59. Park J, Chung ME. Botulinum Toxin for Central Neuropathic Pain. Toxins (Basel). 2018 Jun 1;10(6):224. [CrossRef] [PubMed] [PubMed Central]

60. Busch EH, Atchison SR. Steroid celiac plexus block for chronic pancreatitis: results in 16 cases. J Clin Anesth. 1989;1(6):431-3. [CrossRef] [PubMed]

61. Raj M, Chen RY. Interventional applications of endoscopic ultrasound. J Gastroenterol Hepatol. 2006 Feb;21(2):348-57. [CrossRef] [PubMed]

62. Draganov P, Toskes PP. Chronic pancreatitis. Curr Opin Gastroenterol. 2002 Sep;18(5):558-62. [CrossRef] [PubMed]

63. Strand DS, Law RJ, Yang D, Elmunzer BJ. AGA Clinical Practice Update on the Endoscopic Approach to Recurrent Acute and Chronic Pancreatitis: Expert Review. Gastroenterology. 2022 Oct;163(4):1107-1114. [CrossRef] [PubMed]

64. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009 Nov;54(11):2330-7. [CrossRef] [PubMed]

Published

2024-09-29

How to Cite

Biloshytsky, V. V., & Romanukha, D. M. (2024). Results of interventions on the celiac plexus in treating patients with chronic pharmacoresistant abdominal pain. Ukrainian Neurosurgical Journal, 30(3), 18–29. https://doi.org/10.25305/unj.301385

Issue

Section

Original articles